According to ARRS’ American Journal of Roentgenology (AJR), recent European multisociety guidelines proposing routine surveillance of essentially all gallbladder polyps, especially a 2 mm size change as the basis for cholecystectomy, are likely too conservative for clinical application

60-Year-Old Woman With Chronic Hepatitis B. 

(A) Transverse grayscale ultrasound shows lobulated nondependent 9 mm polyp.

(B) Ultrasound 12 months later shows polyp has increased in size to 11 mm.


September 24, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), recent European multisociety guidelines proposing routine surveillance of essentially all gallbladder polyps, especially a 2 mm size change as the basis for cholecystectomy, are likely too conservative for clinical application.

“To our knowledge,” wrote corresponding author Aya Kamaya, M.D., of Stanford Hospital and Clinics in California, “our study is the first conducted in the United States to longitudinally evaluate gallbladder polyps exclusively in patients with underlying liver disease.”

Kamaya and colleagues’ retrospective study included patients who underwent at least one screening ultrasound examination between January 2010 and December 2020, as part of a hepatocellular carcinoma (HCC) screening and surveillance program that demonstrated a gallbladder polyp.

Among the 434 patients (248 male, 186 female; mean age, 50.6 years) with incidental gallbladder polyps who underwent serial ultrasound examinations for HCC surveillance (range, 2–19 examinations; mean interval between first and last examinations, 3.6 years), the polyps fluctuated—increased and decreased on serial examinations—in number and size in 22% and 18% of patients, respectively. No gallbladder carcinoma was identified in the 19 patients who underwent cholecystectomy.

 

Acknowledging that gallbladder polyps can fluctuate in both size and number over serial examinations, and may even fluctuate in visibility, “using a 2 mm threshold for growth,” the authors of this AJR article concluded, “10% increased in size."

For more information: www.arrs.org

Related Content

News | Ultrasound Imaging

October 15, 2021 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ...

Time October 15, 2021
arrow
News | Radiology Imaging

October 6, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), liver stiffness measurements (LSM) ...

Time October 06, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Cardiovascular Ultrasound

October 5, 2021 – UltraSight, a digital health company developing artificial intelligence (AI) enabled cardiac imaging ...

Time October 05, 2021
arrow
News | Ultrasound Imaging

October 5, 2021 — Ultrasound experts urged the health care community to work to expand utilization of ultrasound ...

Time October 05, 2021
arrow
News | Radiology Business

September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software ...

Time September 27, 2021
arrow
News | Radiology Business

September 23, 2021 — GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
Feature | Breast Imaging | By Jennifer Meade

The breast ultrasound market is seeing growth, driven largely by the proliferation of recent legislation aimed at ...

Time September 15, 2021
arrow
News | Cardiovascular Ultrasound

September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and ...

Time September 14, 2021
arrow
Subscribe Now